Therapeutic Utility of Non-Peptidic CRF1 Receptor Antagonists in Anxiety, Depression, and Stress-Related Disorders: Evidence From Animal Models

Pharmacology and Therapeutics - United Kingdom
doi 10.1016/j.pharmthera.2010.08.011
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Neuroactive Steroids and Neurosteroids in the Mechanisms of Depression and Anxiety Disorders: Potential Therapeutic Opportunities in Depression and Anxiety Disorders

Farmacja Polska
2018English

Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- And Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2005English

SST3-selective Potent Peptidic Somatostatin Receptor Antagonists

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2009English

Anxiety, Depression and Stress in Pregnancy

Current Opinion in Psychiatry
PsychiatryMental Health
2012English

Deep Brain Stimulation in Animal Models of Fear, Anxiety, and Posttraumatic Stress Disorder

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2016English

Recent Developments in the Field of Non Peptidic Α Vβ 3 Antagonists

2012English

Predictors of Depression, Stress, and Anxiety Among Non-Tenure Track Faculty

Frontiers in Psychology
Psychology
2014English

Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence From a Review of the Molecular Mechanisms and Animal Models

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy